(2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(5-iodo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate

Catalog No.: 
ACEIDS675
CAS No.: 
65499-40-3
Molecular Formula: 
C15H17IN2O9
Molecular Weight: 
496.21
(2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(5-iodo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$594.00In stockInquiry
1g97%$1484.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(5-iodo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate
IUPAC Name(2R,3R,4R,5R)-2-(acetoxymethyl)-5-(5-iodo-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3,4-diyl diacetate
Molecular FormulaC15H17IN2O9
Molecular Weight496.21
SMILESO=C(NC(C(I)=C1)=O)N1[C@H](O2)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]2COC(C)=O
InChI KeyWPIWKTDTMIYODW-HKUMRIAESA-N
SynonymTriacetyl Uridine;Uridine, 5-iodo-, 2',3',5'-triacetate
CAS No.65499-40-3

Synthetic Route by SureRoute

1. ACEIDS675 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEIDS675 route product structure diagram
    ACEIDS67565499-40-3In Stock
Inquiry

2. ACEIDS675 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEIDS675 route product structure diagram
    ACEIDS67565499-40-3In Stock
Inquiry

3. ACEIDS675 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEIDS675 route product structure diagram
    ACEIDS67565499-40-3In Stock
Inquiry

Comments (0)